Skip to main content

Table 3 Univariate and multivariate analysis of PFS

From: Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Characteristics

Univariate Analyses

Multivariate Analyses

P

HR

95% CI lower

95% CI upper

P

HR

95% CI lower

95% CI upper

Age (Continuous)

0.355

0.991

0.973

1.010

    

Gender

 Male

 

1.000

      

 Female

0.743

1.060

0.748

1.502

    

Nodal status

 N0

 

1.000

      

 N1/N2

0.007

1.800

1.171

2.767

0.283

0.741

0.428

1.282

Stages

 I

 

1.000

      

 II

0.004

2.604

1.347

5.033

0.018

2.781

1.191

6.492

 III

< 0.001

3.408

1.918

6.053

0.002

3.474

1.599

7.548

RT strategy

 SBRT

 

1.000

      

 EBRT

0.001

3.160

1.572

6.355

0.005

2.779

1.353

5.710

Therapeutic strategy

 TKI alone

 

1.000

      

 R + TKI

< 0.001

0.465

0.326

0.662

< 0.001

0.420

0.291

0.605

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us